The Japanese pharmaceutical company is grappling with a scandal, and Oasis thinks it can help right the ship.
manufactures and sells pharmaceuticals and consumer products in Japan and internationally. The company operates in three segments: The Domestic Business and International Business segments offer health care, household, skin care and other products. The Company recently merged its mail-order segment into its domestic business segment, which is engaged in the mail-order sale of dietary supplements, skin care and other products.
Now, Oasis reported a 5.20% stake in the company, likely a sign that the activist is ready to begin engaging management more aggressively. It is clear to us that Kobayashi needs a reset and that Oasis is a willing and able partner to do so, but it is yet to be seen if the newly appointed CEO and shaken board will play ball.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Activist Oasis suggests three steps to build shareholder value at embattled Kobayashi PharmaceuticalThe Japanese pharmaceutical company is grappling with a scandal, and Oasis thinks it can help right the ship.
Les mer »
Kobayashi: Bosses quit as Japan drugmaker probes deathsPresident and chairman of Kobayashi Pharmaceutical resign as investigation into dozens of deaths continues.
Les mer »
JD Vance Sounds Alarm on China Controlling U.S. Pharmaceutical Supply: ‘Let’s Make Our Own Stuff’Source of breaking news and analysis, insightful commentary and original reporting, curated and written specifically for the new generation of independent and conservative thinkers.
Les mer »
How FTC's Battle With PBMs Could Reshape The Pharmaceutical IndustryI’m an internationally recognized consultant and author with over 25 years of experience in the field of strategy development and execution, business model design, and market analysis.
Les mer »
Hazmat team responds to strange odor call at pharmaceutical company on southeast sideThis is one of the nation's most popular dog shows.
Les mer »
One-step synthesis of pharmaceutical building blocks: New method for anti-Michael reactionIn 1887, chemist Sir Arthur Michael reported a nucleophilic addition reaction to the β-position of α,β- unsaturated carbonyl compounds. These reactions, named Michael addition reactions, have been extensively studied to date.
Les mer »